| Name | Title | Contact Details |
|---|---|---|
Kevin Dahill |
Interim Chief Financial Officer | Profile |
Wayne Coll |
Chief Financial Officer | Profile |
Kern Surgical Supply is a Bakersfield, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ivoclar Vivadent, Inc. is dedicated to delivering a total quality experience that consistently meets or exceeds the customer`s expectations. The customer may be external, the people to whom we sell our products, or internal, the people with whom we interact on a daily basis in attempting to achieve our corporate mission. “To serve dentistry through innovation, quality products, value-added service, a commitment to our people and continually improving as a world class company”.
ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.
NXC Imaging is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
We are a medical technology company developing next-generation solutions for the treatment of chronic venous insufficiency, a progressive medical condition affecting an estimated 10% of adults.